Related references
Note: Only part of the references are listed.Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations
Anton Pottegard et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2018)
Agreement between paternal self-reported medication use and records from a national prescription database
Jacqueline M. Cohen et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2018)
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Andrea C. Tricco et al.
ANNALS OF INTERNAL MEDICINE (2018)
Primary versus secondary source of data in observational studies and heterogeneity in meta-analyses of drug effects: a survey of major medical journals
Guillermo Prada-Ramallal et al.
BMC MEDICAL RESEARCH METHODOLOGY (2018)
Diverging Conclusions from the Same Meta-Analysis in Drug Safety: Source of Data (Primary Versus Secondary) Takes a Toll
Guillermo Prada-Ramallal et al.
DRUG SAFETY (2017)
Clinical outcomes research in gynecologic oncology
Alexander Melamed et al.
GYNECOLOGIC ONCOLOGY (2017)
Immeasurable time bias due to hospitalization in medico-administrative databases: which impact for pharmacoepidemiological studies?
Aurore Palmaro et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
Quantification of missing prescriptions in commercial claims databases: results of a cohort study
Maria Soledad Cepeda et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
Misclassification of incident hospitalized and outpatient heart failure in administrative claims data: the Atherosclerosis Risk in Communities (ARIC) study
Ricky Camplain et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
Evaluating the risk of pneumonia with inhaled corticosteroids in COPD: Retrospective database studies have their limitations SA
J. Bourbeau et al.
RESPIRATORY MEDICINE (2017)
Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and Implications
Rachel B. Weinstein et al.
DRUG SAFETY (2017)
The impact of the lookback period and definition of confirmatory events on the identification of incident cancer cases in administrative data
Jonas Czwikla et al.
BMC MEDICAL RESEARCH METHODOLOGY (2017)
Summarising the Evidence for Drug Safety: A Methodological Discussion of Different Meta-Analysis Approaches
Guillermo Prada-Ramallal et al.
DRUG SAFETY (2017)
Confounding by drug formulary restriction in pharmacoepidemiologic research
Kristian B. Filion et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2016)
Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available
Miguel A. Hernan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)
Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies
Mohammad Ehsanul Karim et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)
Methodological issues on the use of administrative data in healthcare research: the case of heart failure hospitalizations in Lombardy region, 2000 to 2012
Cristina Mazzali et al.
BMC HEALTH SERVICES RESEARCH (2016)
Considerations for the Analysis of Longitudinal Electronic Health Records Linked to Claims Data to Study the Effectiveness and Safety of Drugs
K. J. Lin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Does Metformin Reduce Cancer Risks? Methodologic Considerations
Asieh Golozar et al.
CURRENT DIABETES REPORTS (2016)
Use of Prescription Drug Samples in the USA: A Descriptive Study with Considerations for Pharmacoepidemiology
Christian Hampp et al.
DRUG SAFETY (2016)
Learning About Missing Data Mechanisms in Electronic Health Records-based Research A Survey-based Approach
Sebastien Haneuse et al.
EPIDEMIOLOGY (2016)
Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies
Aurore Palmaro et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2016)
Distinguishing Selection Bias and Confounding Bias in Comparative Effectiveness Research
Sebastien Haneuse
MEDICAL CARE (2016)
Comparative effectiveness research with administrative health data in rheumatoid arthritis
Marie Hudson et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Field studies versus database studies on the risks and benefits of medication use during pregnancy: Distinct pieces of the same puzzle
Anick Berard et al.
REPRODUCTIVE TOXICOLOGY (2016)
Understanding and Avoiding Immortal-Time Bias in Gastrointestinal Observational Research
Laura E. Targownik et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Using Administrative Data to Examine Health Disparities and Outcomes in Neurological Diseases of the Elderly
Allison W. Willis
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2015)
Electronic Health Data for Postmarket Surveillance: A Vision Not Realized
Thomas J. Moore et al.
DRUG SAFETY (2015)
Addressing Limitations in Observational Studies of the Association Between Glucose-Lowering Medications and All-Cause Mortality: A Review
Elisabetta Patorno et al.
DRUG SAFETY (2015)
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
Emily Herrett et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)
Active-comparator design and new-user design in observational studies
Kazuki Yoshida et al.
NATURE REVIEWS RHEUMATOLOGY (2015)
Chances and challenges of using routine data collections for renal health care research
Georg Heinze et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Identifying health outcomes in healthcare databases
Stephan Lanes et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2015)
Methodological considerations in assessing the effectiveness of antidepressant medication continuation during pregnancy using administrative data
Sonja A. Swanson et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2015)
French health insurance databases: What interest for medical research
G. Moulis et al.
REVUE DE MEDECINE INTERNE (2015)
The use of a clinical database in an anesthesia unit: focus on its limits
Gregoire Weil et al.
JOURNAL OF CLINICAL MONITORING AND COMPUTING (2015)
Guidance for conducting systematic scoping reviews
Micah D. J. Peters et al.
INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE (2015)
Immortal Time Bias in Observational Studies of Drug Effects in Pregnancy
Ilan Matok et al.
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2014)
Considerations in using registry and health plan data for studying pregnancy in rheumatic diseases
Jie Zhang et al.
CURRENT OPINION IN RHEUMATOLOGY (2014)
Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations
Elisabetta Patorno et al.
DIABETOLOGIA (2014)
Restrictive Reimbursement Policies: Bias Implications for Claims-Based Drug Safety Studies
Joshua J. Gagne
DRUG SAFETY (2014)
Sources of heterogeneity in case-control studies on associations between statins, ACE-inhibitors, and proton pump inhibitors and risk of pneumonia
Mark C. H. de Groot et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2014)
Scoping reviews: time for clarity in definition, methods, and reporting
Heather L. Colquhoun et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2014)
Use of administrative medical databases in population-based research
Natalie Gavrielov-Yusim et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2014)
Comparative Effectiveness of Two Anemia Management Strategies for Complex Elderly Dialysis Patients
Yi Zhang et al.
MEDICAL CARE (2014)
Evidence of Sample Use Among New Users of Statins Implications for Pharmacoepidemiology
Xiaojuan Li et al.
MEDICAL CARE (2014)
Learning from Big Health Care Data
Sebastian Schneeweiss
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendations
Dae Hyun Kim et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2014)
Confounding by indication affects antimicrobial risk factors for methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition
Rupak Datta et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2014)
A Pathway to Improved Prospective Observational Post-Authorization Safety Studies
Victor A. Kiri
DRUG SAFETY (2013)
Potential Bias in Medication Adherence Studies of Prevalent Users
Matthew L. Maciejewski et al.
HEALTH SERVICES RESEARCH (2013)
Drug exposure: inclusion of dispensed drugs before pregnancy may lead to underestimation of risk associations
Svetlana Skurtveit et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Challenges in Using Electronic Health Record Data for CER Experience of 4 Learning Organizations and Solutions Applied
K. Bruce Bayley et al.
MEDICAL CARE (2013)
Caveats for the Use of Operational Electronic Health Record Data in Comparative Effectiveness Research
William R. Hersh et al.
MEDICAL CARE (2013)
Completeness of prescription information in US commercial claims databases
Julie C. Lauffenburger et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
Review of inverse probability weighting for dealing with missing data
Shaun R. Seaman et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2013)
Informative censoring in relative survival
Anamarija Rebolj Kodre et al.
STATISTICS IN MEDICINE (2013)
Role of electronic health records in comparative effectiveness research
Blanca Gallego et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2013)
Methodological Challenges in Observational Research: A Pharmacoepidemiological Perspective
Ayad K. Ali
BRITISH JOURNAL OF PHARMACEUTICAL RESEARCH (2013)
Propensity Score Calibration in the Absence of Surrogacy
Mark Lunt et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
Bias in Observational Studies of Prevalent Users: Lessons for Comparative Effectiveness Research From a Meta-Analysis of Statins
Goodarz Danaei et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
ADDRESSING MISSING DATA MECHANISM UNCERTAINTY USING MULTIPLE-MODEL MULTIPLE IMPUTATION: APPLICATION TO A LONGITUDINAL CLINICAL TRIAL
Juned Siddique et al.
ANNALS OF APPLIED STATISTICS (2012)
Restrictive Drug Coverage Policies can Induce Substantial Drug Exposure Misclassification in Pharmacoepidemiologic Studies
John-Michael Gamble et al.
CLINICAL THERAPEUTICS (2012)
Metformin and the Risk of Cancer Time-related biases in observational studies
Samy Suissa et al.
DIABETES CARE (2012)
Addressing different biases in analysing drug use on cancer risk in diabetes in non-clinical trial settings-what, why and how?
X. L. Yang et al.
DIABETES OBESITY & METABOLISM (2012)
Utilization of health care databases for pharmacoepidemiology
Yasuo Takahashi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Administrative database research has unique characteristics that can risk biased results
Carl van Walraven et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2012)
Comparative Effectiveness Research in Oncology Methodology: Observational Data
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Challenges in the design and analysis of sequentially monitored postmarket safety surveillance evaluations using electronic observational health care data
Jennifer C. Nelson et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
Quantifying the Impact of Drug Exposure Misclassification due to Restrictive Drug Coverage in Administrative Databases: A Simulation Cohort Study
John-Michael Gamble et al.
VALUE IN HEALTH (2012)
Increased cancer risk with drug use among patients with diabetes: Are the biased methods the culprit?
Xilin Yang et al.
JOURNAL OF DIABETES INVESTIGATION (2012)
Signal Detection and Monitoring Based on Longitudinal Healthcare Data
Marc Suling et al.
Pharmaceutics (2012)
Nonexperimental Comparative Effectiveness Research Using Linked Healthcare Databases
Til Stuermer et al.
EPIDEMIOLOGY (2011)
Sensitivity Analysis When Data Are Missing Not-at-random
Noemie Resseguier et al.
EPIDEMIOLOGY (2011)
With Great Data Comes Great Responsibility Publishing Comparative Effectiveness Research in EPIDEMIOLOGY
Miguel A. Hernan
EPIDEMIOLOGY (2011)
The New World of Data Linkages in Clinical Epidemiology Are We Being Brave or Foolhardy?
Noel S. Weiss
EPIDEMIOLOGY (2011)
Improving Automated Database Studies
Wayne A. Ray
EPIDEMIOLOGY (2011)
Time-window Bias in Case-control Studies
Samy Suissa et al.
EPIDEMIOLOGY (2011)
Administrative database research infrequently used validated diagnostic or procedural codes
Carl van Walraven et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Healthy User and Related Biases in Observational Studies of Preventive Interventions: A Primer for Physicians
William H. Shrank et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2011)
Epidemiologic Research Using Administrative Databases: Garbage In, Garbage Out
Karen W. Hoover et al.
OBSTETRICS AND GYNECOLOGY (2011)
Stratum-specific positive predictive values of claims for acute pancreatitis among commercial health insurance plan enrollees with diabetes mellitus
David D. Dore et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Potential and Pitfalls of Using Large Administrative Claims Data to Study the Safety of Osteoporosis Therapies
Jie Zhang et al.
CURRENT RHEUMATOLOGY REPORTS (2011)
Treatment Effects in the Presence of Unmeasured Confounding: Dealing With Observations in the Tails of the Propensity Score Distribution-A Simulation Study
Til Stuermer et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Confounding Control in Healthcare Database Research Challenges and Potential Approaches
M. Alan Brookhart et al.
MEDICAL CARE (2010)
Epidemiologic Research Using Administrative Databases Garbage In, Garbage Out
David A. Grimes
OBSTETRICS AND GYNECOLOGY (2010)
Pharmacoepidemiological research using French reimbursement databases: yes we can!
Karin Martin-Latry et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Instrumental variable methods in comparative safety and effectiveness research
M. Alan Brookhart et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Avoiding Common Pitfalls in the Analysis of Observational Studies of New Treatments for Rheumatoid Arthritis
Marie Hudson et al.
ARTHRITIS CARE & RESEARCH (2010)
Medical databases in studies of drug teratogenicity: methodological issues
Vera Ehrenstein
Clinical Epidemiology (2010)
Testing bias in clinical databases: methodological considerations
Karin J. Velthove et al.
EMERGING THEMES IN EPIDEMIOLOGY (2010)
Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
Linda E. Levesque et al.
BRITISH MEDICAL JOURNAL (2010)
Regulatory and ethical considerations for linking clinical and administrative databases
Rachel S. Dokholyan et al.
AMERICAN HEART JOURNAL (2009)
RE: IMMORTAL TIME BIAS IN PHARMACOEPIDEMIOLOGY
Victor A. Kiri et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Assessing Residual Confounding of the Association between Antipsychotic Medications and Risk of Death using Survey Data
Sebastian Schneeweiss et al.
CNS DRUGS (2009)
Pharmacovigilance of Biopharmaceuticals Challenges Remain
Thijs J. Giezen et al.
DRUG SAFETY (2009)
Using Secondary Data Sources for Pharmacoepidemiology and Outcomes Research
Spencer E. Harpe
PHARMACOTHERAPY (2009)
Use of disease risk scores in pharmacoepidemiologic studies
Patrick G. Arbogast et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2009)
The case-crossover study design in pharmacoepidemiology
Joseph A. 'Chris' Delaney et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2009)
Missing data methods in longitudinal studies: a review
Joseph G. Ibrahim et al.
TEST (2009)
Immeasurable time bias in observational studies of drug effects on mortality
Samy Suissa
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Immortal time bias in pharmacoepidemiology
Samy Suissa
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Limits of observational data in determining outcomes from cancer therapy
Sharon H. Giordano et al.
CANCER (2008)
Missing Confounding Data in Marginal Structural Models: A Comparison of Inverse Probability Weighting and Multiple Imputation
Erica E. M. Moodie et al.
(2008)
Establishment of a pharmacoepidemiological database in Germany: Methodological potential, scientific value and practical limitations
Iris Pigeot et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Methodologic challenges to studying patient safety and comparative effectiveness
Brian L. Strom
MEDICAL CARE (2007)
Methodological considerations in using claims databases to evaluate persistence with bisphosphonates for osteoporosis
Joyce A. Cramer et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
The impact of residual and unmeasured confounding in epidemiologic studies: A simulation study
Zoe Fewell et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Health state information derived from secondary databases is affected by multiple sources of bias
Darcey D. Terris et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)
Immortal time bias in observational studies of drug effects
Samy Suissa
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Application of lag-time into exposure definitions to control for protopathic bias
H. Tamim et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database
Frank de Vries et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2006)
Variable selection for propensity score models
M. Alan Brookhart et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics
Sebastian Schneeweiss
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2006)
Use of health care databases in pharmacoepidemiology
S Hennessy
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2006)
Observational studies of inhaled corticosteroids in chronic obstructive pulmonary disease: Misconstrued immortal time bias
S Suissa
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Bias due to false-positive diagnoses in an automated health insurance claims database
Stephan F. Lanes et al.
DRUG SAFETY (2006)
Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making
M Etminan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Claims data studies of sedative-hypnotics and hip fractures in older people: Exploring residual confounding using survey information
S Schneeweiss et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Bias in observational study of the effectiveness of nasal corticosteroids in asthma
S Suissa et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
A review of uses of health care utilization databases for epidemiologic research on therapeutics
S Schneeweiss et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2005)
Inhaled steroids and mortality in COPD: bias from unaccounted immortal time
S Suissa
EUROPEAN RESPIRATORY JOURNAL (2004)
A structural approach to selection bias
MA Hernán et al.
EPIDEMIOLOGY (2004)
Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies
S Schneeweiss et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Inhaled steroids and mortality in COPD: bias from unaccounted immortal time
VA Kiri et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders
MS Cepeda et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease - Immortal time bias in observational studies
S Suissa
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Inhaled glucocorticoids in COPD: Immortal time bias
DD Sin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Evaluating medication effects outside of clinical trials: New-user designs
WA Ray
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Misclassification of current benzodiazepine exposure by use of a single baseline measurement and its effects upon studies of injuries
WA Ray et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2002)
Paradoxical relations of drug treatment with mortality in older persons
RJ Glynn et al.
EPIDEMIOLOGY (2001)
Data validity issues in using claims data
BL Strom
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2001)
Rate of heart failure and 1-year survival for older people receiving low-dose β-blocker therapy after myocardial infarction
PA Rochon et al.
LANCET (2000)
Marginal structural models and causal inference in epidemiology
JM Robins et al.
EPIDEMIOLOGY (2000)
Share Paper
